Esperion Therapeutics Reports Financial Details, Corporate UpdateEsperion Therapeutics Inc. (Nasdaq: ESPR), an early-stage pharmaceutical company developing a new class of cholesterol-fighting drugs, Monday provided financial figures and a corporate update.
Tim Mayleben Named President And CEO Of Esperion TherapeuticsEsperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.

More From CBS Detroit

Best Cooking Classes In DetroitLearn how to whip up some wonderful dishes while having fun!
5 Bucket List Items To Cross Off In DetroitThe “must-do” items for anyone making a trip to Detroit.
Best Spots For A Quick Lunch In Downtown DetroitThese places will get you in and out.

Watch & Listen LIVE